[1] |
黄海涛, 耿旭, 尚艳秋, 等. 2005—2016年中国喉癌发病及死亡趋势分析[J]. 中国全科医学, 2022, 25(5):608-614.
|
[2] |
NOCINI R, MOLTENI G, MATTIUZZI C, et al. Updates on larynx cancer epidemiology[J]. Chin J Cancer Res, 2020, 32(1):18-25.
|
[3] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
|
[4] |
MAHDIAN-SHAKIB A, DOROSTKAR R, TAT M, et al. Differential role of microRNAs in prognosis,diagnosis,and therapy of ovarian cancer[J]. Biomed Pharmacother, 2016, 84:592-600.
|
[5] |
TIAN Q, LU Y, YAN B, et al. Integrative bioinformatics analysis reveals that miR-524-5p/MEF2C regulates bone metastasis in prostate cancer and breast cancer[J]. Comput Math Methods Med, 2022, 2022:5211329.
|
[6] |
ZHANG J, WANG P, CUI Y. Long noncoding RNA NEAT1 inhibits the acetylation of PTEN through the miR-524-5p /HDAC1 axis to promote the proliferation and invasion of laryngeal cancer cells[J]. Aging(Albany NY), 2021, 13(22):24850-24865.
|
[7] |
ASKARI N, PIROUZ M S, MAFIKANDI V, et al. The lncRNA UCA1 enhances pancreatic cancer EMT by regulating miR-708-5p and miR-135b-5p:a bioinformatics approach[J]. Iran J Public Health, 2024, 53(7):1659-1669.
|
[8] |
WU X, TAN Y, TANG X. Long noncoding RNA MALAT1 promotes laryngocarcinoma development by targeting miR-708-5p/BRD4 axis to regulate YAP1-mediated epithelial-mesenchymal transition[J]. Biomed Res Int, 2022, 2022:8093949.
|
[9] |
左文娜, 朱虹, 金爱燕, 等. 沉默MMP-9对喉癌细胞侵袭、迁移及PI3K/Akt磷酸化水平的影响[J]. 疑难病杂志, 2021, 20(10):987-991+996.
|
[10] |
JI Z, FANG Z, DONG X, et al. Potential ferroptosis-related diagnostic and prognostic biomarkers in laryngeal cancer[J]. Eur Arch Otorhinolaryngol, 2022, 279(11):5277-5288.
DOI
PMID
|
[11] |
MACNEIL S D. Non-squamous laryngeal cancer[J]. Otolaryngol Clin North Am, 2023, 56(2):345-359.
|
[12] |
JIANG S, YAN J, CHEN X, et al. Ginsenoside Rh2 inhibits thyroid cancer cell migration and proliferation via activation of miR-524-5p[J]. Arch Med Sci, 2020, 18(1):164-170.
|
[13] |
ZHEN W, QIU D, ZHIYONG C, et al. MicroRNA-524-5p functions as a tumor suppressor in a human pituitary tumor-derived cell line[J]. Horm Metab Res, 2017, 49(7):550-557.
DOI
PMID
|
[14] |
LIU G H, LIU Y H, YANG Z, et al. MicroRNA-524-5p suppresses the growth and invasive abilities of gastric cancer cells[J]. Oncol Lett, 2016, 11(3):1926-1932.
|
[15] |
李顺乐, 张迪, 常帅, 等. circPUM1通过调控miR-524-5p表达对结肠癌细胞恶性生物学行为的影响[J]. 胃肠病学和肝病学杂志, 2021, 30(4):382-390.
|
[16] |
华国安, 王蓉, 黄笑欢, 等. 微RNA-524-5p通过靶向抑制SOX9基因表达增加胃癌细胞的顺铂敏感性[J]. 肿瘤, 2019, 39(8):606-615.
|
[17] |
LIN K T, YEH Y M, CHUANG C M, et al. Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B[J]. Nat Commun, 2015, 6:5917.
|
[18] |
WU X, LIU T, FANG O, et al. MicroRNA-708-5p acts as a therapeutic agent against metastatic lung cancer[J]. Oncotarget, 2016, 7(3):2417-2432.
DOI
PMID
|
[19] |
丰天宇, 朱中凯, 王豪, 等. microRNA-708-5p对骨肉瘤细胞凋亡与迁移的作用及机制[J]. 中国细胞生物学学报, 2019, 41(3):446-455.
|
[20] |
WANG H, XU T, WU L, et al. Molecular mechanisms of MCM3AP-AS1 targeted the regulation of miR-708-5p on cell proliferation and apoptosis in gastric cancer cells[J]. Eur Rev Med Pharmacol Sci, 2021, 25(20):6159.
|
[21] |
YU Y, CHANG Z, HAN C, et al. Long non-coding RNA MINCR aggravates colon cancer via regulating miR-708-5p-mediated Wnt/β-catenin pathway[J]. Biomed Pharmacother, 2020, 129:110292.
DOI
PMID
|
[22] |
郑宏, 曾振华, 唐建生, 等. circ-RAD23B通过miR-708-5p/CPNE1轴调控膀胱癌细胞增殖、细胞周期、凋亡的机制[J]. 中国老年学杂志, 2022, 42(17):4314-4320.
|